Home > Node

UK: Medical Robotics for Contagious Diseases Challenge 2020

Across the world, robots and drones are being repurposed and deployed as part of the COVID-19 response. For example: There are robots disinfecting hospitals or automated systems supporting the testing of millions of people. The UK Robotics and Autonomous Systems Network is running an online challenge for the use of medical robot technologies in areas such as disease prevention, diagnostics, screening, patient care and disease management. Key deadlines: Submission of video entries: 30 September Review and acceptance: 14 October Final video, presentation & two-page paper: 28 October Online...
Read more

EU Guidance for a Safe Return to the Workplace

The European Agency for Safety and Health at Work (EU-OSHA) has issued guidance for a safe return to the workplace. The guidelines include examples of general measures, which , depending on the particular work situation, can help employers achieve an appropriate safe and healthy work environment when resuming activities. The guidance covers several areas: Risk assessment and appropriate measures Involving...Read more
Read more

Studies on COVID-19 and its impact

At the start of the crisis, Orkestra created the COVID-19 Regional Competitiveness Observatory with the intention of providing analysis and reflections to support responses to the socioeconomic impacts that COVID-19 is generating in all regions. The observatory includes two main sections: A more analytical section where you can find specific reports on the impacts of COVID-19 . The first in this...
Read more
  • Apr 30, 2020
  • Audry Maulana

Economic response against COVID-19 pandemic

To cushion the blow to people’s livelihoods and the economy, the European Commission has adopted a comprehensive economic response to the outbreak , applied the full flexibility of the EU fiscal rules , has revised its State Aid rules and set up a €37 billion Coronavirus Response Investment Initiative to provide liquidity to small businesses and the health care sector. In addition, on 2 April, the...Read more
Read more

Answers from the NYT to your COVID-19 questions

The New York Times has launched a booklet with answers to pressing questions about the Coronavirus: symptoms, social distancing and more. It is based on the contributions of hundreds of reporters and editors working around the clock and on multiple continents to understand and explain the coronavirus outbreak and its effects. Written from a journalist perspective, the booklet gives an overview on...
Read more
  • Apr 24, 2020
  • Audry Maulana

Postponement of Medical Devices Regulation

The European Commission welcomes the adoption by the European Parliament and the Council of the proposal to postpone by one year the date of application of the Medical Devices Regulation . This will allow all key players - Member States, health institutions and economic operators to give priority to the fight against the ongoing coronavirus pandemic, forming a key position in the timing of the lifting of...Read more
Read more

COVID-19 impacts on INTERREG project

The INTERREG project CHAIN REACTIONS that aims on “Driving smart industrial growth through value chain innovation” , will adjust its activities in order to reflect the current COVID-19 pandemic and its potential impacts on industrial value chains in the Central Europe region. The project deals with five key sectors based on their embedding in regional smart specialization strategies. These...
Read more
  • Apr 23, 2020
  • Audry Maulana

Macro-Financial Assistance Package for Neighbouring Countries

The European Commission has adopted a proposal for a €3 billion macro-financial assistance (MFA) package to ten enlargement and neighbourhood partners to help them to limit the economic fallout of the COVID-19 pandemic . Following a preliminary assessment of financing needs, the MFA-proposal determines funds to be distributed as follows: the Republic of Albania (€180 million), Bosnia and Herzegovina (€250...Read more
Read more

GERMANY: First clinical trial of COVID-19 vaccine approved

The German biotech companies BioNTech SE and Pfizer Inc . have announced that the German regulatory authority, the Paul-Ehrlich-Institut , has approved the Phase 1/2 clinical trial for BioNTech’s BNT162 vaccine program to prevent COVID-19 infection . The trial is the first clinical trial of a COVID-19 vaccine candidate to start in Germany, and is part of a global development programme. The...
Read more
  • Apr 23, 2020
  • Audry Maulana

FRANCE: Special Newsletter on COVID-19 Action

France Clusters has published new newsletters that aim to capitalisate initiatives and to enable readers to draw lessons at the end of the Covid-19 crisis. The newsletters is called PROJET SIMAC ( Suivi des Initiatives, Mesures, Actualités liées à la crise COVID19 ). To read edition 5 of this newsletter (in French) please click here . To read more newsletters and gain access to France Clusters...
Read more
  • Apr 23, 2020
  • Audry Maulana

Pages